🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study attempts to conduct randomized double-blind controlled trials to ...
Status
Completed
Location
School of Public Health, Fudan University
Start Date
2025-11-30
Trial ID
NCT07416214
Treatments Being Tested
assessment of healing potentiality of peri apical lesions using different d...
Status
Unknown
Location
Ain Shams university
Start Date
2023-12-20
Trial ID
NCT06164509
Treatments Being Tested
This a double blind randomised controlled trial (RCT) to determine the effe...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-10
Trial ID
NCT03155477
Treatments Being Tested
This study will assess the efficacy of boceprevir (BOC) in combination with...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-21
Trial ID
NCT01390844
This is a Phase I randomized double-blind, placebo-controlled, single and m...
Status
Completed
Location
Research Site
Start Date
2010-04
Trial ID
NCT01114152
Arm 1: Primary Objective: • To determine the safety and tolerability of m...
Status
Completed
Location
Covance Clinical Pharmacology, Inc.
Start Date
2010-05
Trial ID
NCT01135680
Treatments Being Tested
In this study,189 adult migraine patients aged 18-65 years (diagnosed with ...
Status
Unknown
Location
The Affiliated Hospital of Southwest Medical University
Start Date
2023-06-01
Trial ID
NCT05484349
Treatments Being Tested
Assess the safety, tolerability and pharmacokinetics of multiple oral doses...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-01
Trial ID
NCT00445315
Treatments Being Tested
This study will evaluate the safety and tolerability of MK6186 and the chan...
Status
Terminated
Location
Multiple Locations
Start Date
2010-10-10
Trial ID
NCT01152255
Treatments Being Tested
The purpose of this study is to determine whether olorinab is a safe and ef...
Status
Terminated
Location
Accel Research Sites - Birmingham Clinical Research Unit
Start Date
2019-07-24
Trial ID
NCT04043455